reference/31785027

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31785027

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	2592
issn	0008-5472 1538-7445
issueIdentifier	10
pageRange	2580-2592
publicationName	Cancer Research
startingPage	2580
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0a7aebba2d991405fb4ac780dfb9bb5b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_59232485abba67bc1c13d00ebefea036 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4b6e8764c77ccb973bb37b81c833df3b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_38dd52609870f30e5126756fba888f15 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c58944ec127b22687131476fd9c041ff http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b470728a65ee937568d6572be1f55f8f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_14217850e86f31f7d7be436469665447 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d62f51386142d8e7576b9b70134d6e59 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5bfde0afa593746c42229f339fbd62c6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f36956cbf61cde74504a59644ca1e8a4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0efd1fda8d1ab3795999232d4fddd69b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c1b20f0dd9567bf8b4b9be717437fa05
bibliographicCitation	Li S, Fong KW, Gritsina G, Zhang A, Zhao JC, Kim J, Sharp A, Yuan W, Aversa C, Yang XJ, Nelson PS, Feng FY, Chinnaiyan AM, de Bono JS, Morrissey C, Rettig MB, Yu J. Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer. Cancer Res. 2019 May 15;79(10):2580–92. PMID: 30952632; PMCID: PMC6522281.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b17dba62e24cf0184cffa0fbf5429468 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60ebd39b0747bb55e6c960134d371f1c http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3134-532X http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6274-2841 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d4dee2ff736b4c9202cee1e52d5ed9b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d08bf03834d16555394b5f04e90c569f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b14a512af0c528e46436d7248024bcdc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff3346e222983063a43928d2e8042397 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0171609f48e7a26d702ba5153823aa93 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3740-1612 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e1cdce104321a003ca1f52c627e9f5d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcd5f93d9403f8a2c6813e65cd093e86 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_990093611b33fbfa2ed855c6855510fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61fbcfbff0731fb802413a8d60ed4684 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b6150b6bc4fae9a82a5ebd3c32c26ad http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1972-7798 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce820bc3729125724a01eaf0da8b2fd5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_139739a00f3a95ce83b1e2b2e89f3141 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b0675d3efdec002b52d7f5913c7c67f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3278699f7aba13e0d81dc2875dcf9b21
date	2019-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1158/0008-5472.can-18-2812 https://pubmed.ncbi.nlm.nih.gov/PMC6522281 https://pubmed.ncbi.nlm.nih.gov/30952632
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2786 https://portal.issn.org/resource/ISSN/1538-7445 https://portal.issn.org/resource/ISSN/0008-5472
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer
discusses	http://id.nlm.nih.gov/mesh/M0575714 http://id.nlm.nih.gov/mesh/M0577955 http://id.nlm.nih.gov/mesh/M0014878 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0451182 http://id.nlm.nih.gov/mesh/M0504530 http://id.nlm.nih.gov/mesh/M0016576 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0018261 http://id.nlm.nih.gov/mesh/M0018236
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D054387Q000235 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D064129Q000188 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D010669Q000031 http://id.nlm.nih.gov/mesh/D020935
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D057809 http://id.nlm.nih.gov/mesh/D064129Q000378 http://id.nlm.nih.gov/mesh/D009570 http://id.nlm.nih.gov/mesh/D002455Q000187 http://id.nlm.nih.gov/mesh/D008819 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D001549 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D064129Q000473 http://id.nlm.nih.gov/mesh/D011744Q000494 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D011728Q000494 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D002470 http://id.nlm.nih.gov/mesh/D009361 http://id.nlm.nih.gov/mesh/D010669Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d7ecf8c06ccd27f738eab5f001875b5e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15951529 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f4b26d81e6b84e466752e84f0e9b347d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_36ee25d8dd1eee6718d9061f8ee3bf1e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID57007

Total number of triples: 98.